SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-310657
Filing Date
2020-12-04
Accepted
2020-12-04 16:25:55
Documents
15
Period of Report
2020-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d70283d8k.htm   iXBRL 8-K 26352
2 EX-5.1 d70283dex51.htm EX-5.1 8962
6 GRAPHIC g70283img01.jpg GRAPHIC 25821
7 GRAPHIC g70283img02.jpg GRAPHIC 4072
  Complete submission text file 0001193125-20-310657.txt   205553

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20201204.xsd EX-101.SCH 3094
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20201204_lab.xml EX-101.LAB 18856
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20201204_pre.xml EX-101.PRE 11864
8 EXTRACTED XBRL INSTANCE DOCUMENT d70283d8k_htm.xml XML 3455
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 201370156
SIC: 2834 Pharmaceutical Preparations